• Riccardo De Giorgi on semaglutide and neurological and psychiatric outcomes

  • 2024/08/05
  • 再生時間： 28 分
  • ポッドキャスト

Riccardo De Giorgi on semaglutide and neurological and psychiatric outcomes

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Riccardo De Giorgi joins Elena Bellafante, Deputy Editor for eClinicalMedicine, to discuss the evidence that semaglutide may be associated with a reduced risk of a number of neurological and psychiatric outcomes, including cognitive deficits and dementia, as well as nicotine misuse.

    Read the full article:
    https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00305-5/fulltext?dgcid=buzzsprout_tlv_podcast_generic_eclinm

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Riccardo De Giorgi joins Elena Bellafante, Deputy Editor for eClinicalMedicine, to discuss the evidence that semaglutide may be associated with a reduced risk of a number of neurological and psychiatric outcomes, including cognitive deficits and dementia, as well as nicotine misuse.

Read the full article:
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00305-5/fulltext?dgcid=buzzsprout_tlv_podcast_generic_eclinm

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
身体的病い・疾患 衛生・健康的な生活 生物科学
続きを読む 一部表示

Riccardo De Giorgi on semaglutide and neurological and psychiatric outcomesに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。